AI Automation — Pharmaceuticals
AI Automation for Pharmaceutical Companies
Pharmaceutical manufacturing operates under GMP regulations where documentation is not administrative overhead — it is evidence that the product was made correctly. Batch manufacturing records, analytical testing records, deviation investigations, change control documentation, CAPA management — each is a defined document type with defined content requirements and defined approval sequences. The volume of this documentation in a pharmaceutical manufacturing environment is substantial, and the consequences of error or delay are significant. We build AI automation for pharmaceutical companies that handles the structured documentation and process management layer: batch record review automation that checks completed records against specification requirements, quality event management workflows that route deviations and CAPAs through defined investigation and approval sequences, and regulatory submission documentation tools that compile and track the MHRA and EMA submissions that determine product authorisation.
£30bn
UK pharmaceutical sector annual output
73,000+
Employees in UK pharmaceutical manufacturing
60%
Reduction in batch record review time with automation
21 days
Quality event workflow deployment time
Common pain points
- ×Batch manufacturing record review consuming QA time on routine checks that follow defined rules
- ×CAPA and deviation investigation workflows progressing slowly due to manual routing and chasing
- ×Regulatory submission documentation taking disproportionate regulatory affairs team time to compile and track
What we automate
- ✓Batch record review automation checking completed BMRs against specification requirements and flagging exceptions
- ✓Deviation and CAPA management workflow routing quality events through investigation and approval sequences
- ✓Regulatory submission tracking system managing MHRA and EMA submission timelines and approval status
How AI automation works in Pharmaceuticals
Pharmaceutical quality management generates documentation volumes that are demanding to manage manually — every batch generates a batch manufacturing record, every deviation generates an investigation, every change generates a change control, and every CAPA generates a corrective action trail. The structure of this documentation is defined by GMP guidelines and internal SOPs, which means the review and routing of these documents follows rules that AI can apply consistently and at speed. We build quality and regulatory automation for pharmaceutical companies: batch record review tools that check completed BMRs against specification requirements and flag exceptions for QA review rather than requiring QA to read every page; CAPA and deviation management workflows that route quality events through investigation and approval sequences, chasing overdue responses automatically; and regulatory documentation tools that compile submission evidence packages and track approval status through the MHRA and EMA review process.
Pharmaceutical QA teams deploying batch record review automation recover 40-60% of the time previously spent on routine BMR checking, freeing capacity for complex quality decisions.
AI automation in Pharmaceuticals — overview
AI automation for UK pharmaceutical companies addresses GMP documentation management, quality event workflow, and regulatory submission tracking. Batch manufacturing record review automation applies defined specification checks to completed records, identifying exceptions and missing entries without requiring QA personnel to read every page manually. Deviation and CAPA management automation routes quality events through defined investigation and approval sequences — assigning responsibility, tracking progress, and escalating overdue responses against defined timelines. Regulatory submission documentation automation compiles the evidence packages required for MHRA Clinical Trial Authorisations, Marketing Authorisation Applications, and post-approval variations, and tracks submission status through the regulatory review process. Pharmaceutical QA teams deploying batch record review automation report 40-60% reductions in routine record checking time.
"GMP documentation is not optional — but a QA pharmacist reading every line of every batch record is not the best use of their expertise. AI review that flags exceptions for human judgement applies that expertise where it actually matters."
Technology stack
RAG systems built with Pinecone or Supabase pgvector for grounded, hallucination-free responses. Workflow orchestration via n8n (visual, auditable) or Python services for high-throughput or compliance-sensitive pipelines. LLM selection matched to task — frontier models for nuanced customer-facing responses, smaller classification models for routing and triage. REST API integrations into your CRM, helpdesk, and third-party tools. All deployments ship with documentation, audit logging, and exportable assets — no proprietary lock-in.
Frequently asked questions
What AI automation do you build for pharmaceutical companies?▼
How do you validate AI systems for GMP compliance?▼
Can batch record review automation handle variable record formats?▼
How does CAPA management automation improve investigation timelines?▼
Can your systems assist with MHRA regulatory submission preparation?▼
Related services
Related industries
Ready to automate your Pharmaceuticals workflows?
Book a free 30-minute strategy call. We review your operations, identify the highest-impact automation opportunities, and give a straight answer on what is worth building.